Get Real Time Here
| Open6.000 | Close- |
| Vol / Avg.85.796K / 17.185K | Mkt Cap866.035M |
| Day Range6.000 - 7.431 | 52 Wk Range7.600 - 20.000 |
Curis Stock (NASDAQ:CRIS), Quotes and News Summary
Curis Stock (NASDAQ: CRIS) stock price, news, charts, stock research, profile.
| Open6.000 | Close- |
| Vol / Avg.85.796K / 17.185K | Mkt Cap866.035M |
| Day Range6.000 - 7.431 | 52 Wk Range7.600 - 20.000 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.120 | -0.120 | 0.0000 | ||||
| REV | 2.570M | 2.197M | -373.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-25 | HC Wainwright & Co. | Edward White | Reiterates | BuyBuy | Maintains | - | 6.00 |
| 2023-09-07 | Cantor Fitzgerald | Alethia Young | Reiterates | OverweightOverweight | Maintains | - | 3.00 |
| 2023-08-04 | HC Wainwright & Co. | Edward White | Reiterates | BuyBuy | Maintains | - | 6.00 |
| 2023-07-11 | Cantor Fitzgerald | Alethia Young | Reiterates | OverweightOverweight | Maintains | - | 3.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| CRIS | Curis | 1836.24% | 866M |
| AGLE | Aeglea BioTherapeutics | 0.17% | 46.5M |
| GANX | Gain Therapeutics | 18.18% | 47.9M |
| CNTB | Connect Biopharma Hldgs | -0.17% | 41M |
| VTGN | Vistagen Therapeutics | 0.58% | 48.8M |
How do I buy Curis (CRIS) stock?
You can purchase shares of Curis (NASDAQ: CRIS) through any online brokerage.
Who are Curis's (CRIS) competitors?
Other companies in Curis’s space includes: Aeglea BioTherapeutics (NASDAQ:AGLE), Gain Therapeutics (NASDAQ:GANX), Connect Biopharma Hldgs (NASDAQ:CNTB), Vistagen Therapeutics (NASDAQ:VTGN) and Longeveron (NASDAQ:LGVN).
What is the target price for Curis (CRIS) stock?
The latest price target for Curis (NASDAQ: CRIS) was reported by HC Wainwright & Co. on Monday, September 25, 2023. The analyst firm set a price target for 6.00 expecting CRIS to fall to within 12 months (a possible -18.45% downside). 7 analyst firms have reported ratings in the last year.
Current Stock Price for Curis (CRIS)?
The stock price for Curis (NASDAQ: CRIS) is $7.3577 last updated Today at September 29, 2023 at 2:32 PM UTC.
Does Curis (CRIS) pay a dividend?
There is no dividend information for Curis.
When is Curis (NASDAQ:CRIS) reporting earnings?
Curis’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
Is Curis (CRIS) going to split?
There is no upcoming split for Curis.
What sector and industry does Curis (CRIS) operate in?
Curis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Curis Stock (NASDAQ:CRIS), Quotes and News Summary
Curis Stock (NASDAQ: CRIS) stock price, news, charts, stock research, profile.
| Open6.000 | Close- |
| Vol / Avg.85.796K / 17.185K | Mkt Cap866.035M |
| Day Range6.000 - 7.431 | 52 Wk Range7.600 - 20.000 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.120 | -0.120 | 0.0000 | ||||
| REV | 2.570M | 2.197M | -373.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-25 | HC Wainwright & Co. | Edward White | Reiterates | BuyBuy | Maintains | - | 6.00 |
| 2023-09-07 | Cantor Fitzgerald | Alethia Young | Reiterates | OverweightOverweight | Maintains | - | 3.00 |
| 2023-08-04 | HC Wainwright & Co. | Edward White | Reiterates | BuyBuy | Maintains | - | 6.00 |
| 2023-07-11 | Cantor Fitzgerald | Alethia Young | Reiterates | OverweightOverweight | Maintains | - | 3.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| CRIS | Curis | 1836.24% | 866M |
| AGLE | Aeglea BioTherapeutics | 0.17% | 46.5M |
| GANX | Gain Therapeutics | 18.18% | 47.9M |
| CNTB | Connect Biopharma Hldgs | -0.17% | 41M |
| VTGN | Vistagen Therapeutics | 0.58% | 48.8M |
How do I buy Curis (CRIS) stock?
You can purchase shares of Curis (NASDAQ: CRIS) through any online brokerage.
Who are Curis's (CRIS) competitors?
Other companies in Curis’s space includes: Aeglea BioTherapeutics (NASDAQ:AGLE), Gain Therapeutics (NASDAQ:GANX), Connect Biopharma Hldgs (NASDAQ:CNTB), Vistagen Therapeutics (NASDAQ:VTGN) and Longeveron (NASDAQ:LGVN).
What is the target price for Curis (CRIS) stock?
The latest price target for Curis (NASDAQ: CRIS) was reported by HC Wainwright & Co. on Monday, September 25, 2023. The analyst firm set a price target for 6.00 expecting CRIS to fall to within 12 months (a possible -18.45% downside). 7 analyst firms have reported ratings in the last year.
Current Stock Price for Curis (CRIS)?
The stock price for Curis (NASDAQ: CRIS) is $7.3577 last updated Today at September 29, 2023 at 2:32 PM UTC.
Does Curis (CRIS) pay a dividend?
There is no dividend information for Curis.
When is Curis (NASDAQ:CRIS) reporting earnings?
Curis’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
Is Curis (CRIS) going to split?
There is no upcoming split for Curis.
What sector and industry does Curis (CRIS) operate in?
Curis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Curis Stock (NASDAQ:CRIS), Quotes and News Summary
Curis Stock (NASDAQ: CRIS) stock price, news, charts, stock research, profile.
| Open6.000 | Close- |
| Vol / Avg.85.796K / 17.185K | Mkt Cap866.035M |
| Day Range6.000 - 7.431 | 52 Wk Range7.600 - 20.000 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.120 | -0.120 | 0.0000 | ||||
| REV | 2.570M | 2.197M | -373.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-25 | HC Wainwright & Co. | Edward White | Reiterates | BuyBuy | Maintains | - | 6.00 |
| 2023-09-07 | Cantor Fitzgerald | Alethia Young | Reiterates | OverweightOverweight | Maintains | - | 3.00 |
| 2023-08-04 | HC Wainwright & Co. | Edward White | Reiterates | BuyBuy | Maintains | - | 6.00 |
| 2023-07-11 | Cantor Fitzgerald | Alethia Young | Reiterates | OverweightOverweight | Maintains | - | 3.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| CRIS | Curis | 1836.24% | 866M |
| AGLE | Aeglea BioTherapeutics | 0.17% | 46.5M |
| GANX | Gain Therapeutics | 18.18% | 47.9M |
| CNTB | Connect Biopharma Hldgs | -0.17% | 41M |
| VTGN | Vistagen Therapeutics | 0.58% | 48.8M |
How do I buy Curis (CRIS) stock?
You can purchase shares of Curis (NASDAQ: CRIS) through any online brokerage.
Who are Curis's (CRIS) competitors?
Other companies in Curis’s space includes: Aeglea BioTherapeutics (NASDAQ:AGLE), Gain Therapeutics (NASDAQ:GANX), Connect Biopharma Hldgs (NASDAQ:CNTB), Vistagen Therapeutics (NASDAQ:VTGN) and Longeveron (NASDAQ:LGVN).
What is the target price for Curis (CRIS) stock?
The latest price target for Curis (NASDAQ: CRIS) was reported by HC Wainwright & Co. on Monday, September 25, 2023. The analyst firm set a price target for 6.00 expecting CRIS to fall to within 12 months (a possible -18.45% downside). 7 analyst firms have reported ratings in the last year.
Current Stock Price for Curis (CRIS)?
The stock price for Curis (NASDAQ: CRIS) is $7.3577 last updated Today at September 29, 2023 at 2:32 PM UTC.
Does Curis (CRIS) pay a dividend?
There is no dividend information for Curis.
When is Curis (NASDAQ:CRIS) reporting earnings?
Curis’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
Is Curis (CRIS) going to split?
There is no upcoming split for Curis.
What sector and industry does Curis (CRIS) operate in?
Curis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Curis Stock (NASDAQ:CRIS), Quotes and News Summary
Curis Stock (NASDAQ: CRIS) stock price, news, charts, stock research, profile.
| Open6.000 | Close- |
| Vol / Avg.85.796K / 17.185K | Mkt Cap866.035M |
| Day Range6.000 - 7.431 | 52 Wk Range7.600 - 20.000 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.120 | -0.120 | 0.0000 | ||||
| REV | 2.570M | 2.197M | -373.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-25 | HC Wainwright & Co. | Edward White | Reiterates | BuyBuy | Maintains | - | 6.00 |
| 2023-09-07 | Cantor Fitzgerald | Alethia Young | Reiterates | OverweightOverweight | Maintains | - | 3.00 |
| 2023-08-04 | HC Wainwright & Co. | Edward White | Reiterates | BuyBuy | Maintains | - | 6.00 |
| 2023-07-11 | Cantor Fitzgerald | Alethia Young | Reiterates | OverweightOverweight | Maintains | - | 3.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| CRIS | Curis | 1836.24% | 866M |
| AGLE | Aeglea BioTherapeutics | 0.17% | 46.5M |
| GANX | Gain Therapeutics | 18.18% | 47.9M |
| CNTB | Connect Biopharma Hldgs | -0.17% | 41M |
| VTGN | Vistagen Therapeutics | 0.58% | 48.8M |
How do I buy Curis (CRIS) stock?
You can purchase shares of Curis (NASDAQ: CRIS) through any online brokerage.
Who are Curis's (CRIS) competitors?
Other companies in Curis’s space includes: Aeglea BioTherapeutics (NASDAQ:AGLE), Gain Therapeutics (NASDAQ:GANX), Connect Biopharma Hldgs (NASDAQ:CNTB), Vistagen Therapeutics (NASDAQ:VTGN) and Longeveron (NASDAQ:LGVN).
What is the target price for Curis (CRIS) stock?
The latest price target for Curis (NASDAQ: CRIS) was reported by HC Wainwright & Co. on Monday, September 25, 2023. The analyst firm set a price target for 6.00 expecting CRIS to fall to within 12 months (a possible -18.45% downside). 7 analyst firms have reported ratings in the last year.
Current Stock Price for Curis (CRIS)?
The stock price for Curis (NASDAQ: CRIS) is $7.3577 last updated Today at September 29, 2023 at 2:32 PM UTC.
Does Curis (CRIS) pay a dividend?
There is no dividend information for Curis.
When is Curis (NASDAQ:CRIS) reporting earnings?
Curis’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
Is Curis (CRIS) going to split?
There is no upcoming split for Curis.
What sector and industry does Curis (CRIS) operate in?
Curis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Curis Stock (NASDAQ:CRIS), Quotes and News Summary
Curis Stock (NASDAQ: CRIS) stock price, news, charts, stock research, profile.
| Open6.000 | Close- |
| Vol / Avg.85.796K / 17.185K | Mkt Cap866.035M |
| Day Range6.000 - 7.431 | 52 Wk Range7.600 - 20.000 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.120 | -0.120 | 0.0000 | ||||
| REV | 2.570M | 2.197M | -373.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-25 | HC Wainwright & Co. | Edward White | Reiterates | BuyBuy | Maintains | - | 6.00 |
| 2023-09-07 | Cantor Fitzgerald | Alethia Young | Reiterates | OverweightOverweight | Maintains | - | 3.00 |
| 2023-08-04 | HC Wainwright & Co. | Edward White | Reiterates | BuyBuy | Maintains | - | 6.00 |
| 2023-07-11 | Cantor Fitzgerald | Alethia Young | Reiterates | OverweightOverweight | Maintains | - | 3.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| CRIS | Curis | 1836.24% | 866M |
| AGLE | Aeglea BioTherapeutics | 0.17% | 46.5M |
| GANX | Gain Therapeutics | 18.18% | 47.9M |
| CNTB | Connect Biopharma Hldgs | -0.17% | 41M |
| VTGN | Vistagen Therapeutics | 0.58% | 48.8M |
How do I buy Curis (CRIS) stock?
You can purchase shares of Curis (NASDAQ: CRIS) through any online brokerage.
Who are Curis's (CRIS) competitors?
Other companies in Curis’s space includes: Aeglea BioTherapeutics (NASDAQ:AGLE), Gain Therapeutics (NASDAQ:GANX), Connect Biopharma Hldgs (NASDAQ:CNTB), Vistagen Therapeutics (NASDAQ:VTGN) and Longeveron (NASDAQ:LGVN).
What is the target price for Curis (CRIS) stock?
The latest price target for Curis (NASDAQ: CRIS) was reported by HC Wainwright & Co. on Monday, September 25, 2023. The analyst firm set a price target for 6.00 expecting CRIS to fall to within 12 months (a possible -18.45% downside). 7 analyst firms have reported ratings in the last year.
Current Stock Price for Curis (CRIS)?
The stock price for Curis (NASDAQ: CRIS) is $7.3577 last updated Today at September 29, 2023 at 2:32 PM UTC.
Does Curis (CRIS) pay a dividend?
There is no dividend information for Curis.
When is Curis (NASDAQ:CRIS) reporting earnings?
Curis’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
Is Curis (CRIS) going to split?
There is no upcoming split for Curis.
What sector and industry does Curis (CRIS) operate in?
Curis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Curis Stock (NASDAQ:CRIS), Quotes and News Summary
Curis Stock (NASDAQ: CRIS) stock price, news, charts, stock research, profile.
| Open6.000 | Close- |
| Vol / Avg.85.796K / 17.185K | Mkt Cap866.035M |
| Day Range6.000 - 7.431 | 52 Wk Range7.600 - 20.000 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.120 | -0.120 | 0.0000 | ||||
| REV | 2.570M | 2.197M | -373.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-25 | HC Wainwright & Co. | Edward White | Reiterates | BuyBuy | Maintains | - | 6.00 |
| 2023-09-07 | Cantor Fitzgerald | Alethia Young | Reiterates | OverweightOverweight | Maintains | - | 3.00 |
| 2023-08-04 | HC Wainwright & Co. | Edward White | Reiterates | BuyBuy | Maintains | - | 6.00 |
| 2023-07-11 | Cantor Fitzgerald | Alethia Young | Reiterates | OverweightOverweight | Maintains | - | 3.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| CRIS | Curis | 1836.24% | 866M |
| AGLE | Aeglea BioTherapeutics | 0.17% | 46.5M |
| GANX | Gain Therapeutics | 18.18% | 47.9M |
| CNTB | Connect Biopharma Hldgs | -0.17% | 41M |
| VTGN | Vistagen Therapeutics | 0.58% | 48.8M |
How do I buy Curis (CRIS) stock?
You can purchase shares of Curis (NASDAQ: CRIS) through any online brokerage.
Who are Curis's (CRIS) competitors?
Other companies in Curis’s space includes: Aeglea BioTherapeutics (NASDAQ:AGLE), Gain Therapeutics (NASDAQ:GANX), Connect Biopharma Hldgs (NASDAQ:CNTB), Vistagen Therapeutics (NASDAQ:VTGN) and Longeveron (NASDAQ:LGVN).
What is the target price for Curis (CRIS) stock?
The latest price target for Curis (NASDAQ: CRIS) was reported by HC Wainwright & Co. on Monday, September 25, 2023. The analyst firm set a price target for 6.00 expecting CRIS to fall to within 12 months (a possible -18.45% downside). 7 analyst firms have reported ratings in the last year.
Current Stock Price for Curis (CRIS)?
The stock price for Curis (NASDAQ: CRIS) is $7.3577 last updated Today at September 29, 2023 at 2:32 PM UTC.
Does Curis (CRIS) pay a dividend?
There is no dividend information for Curis.
When is Curis (NASDAQ:CRIS) reporting earnings?
Curis’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
Is Curis (CRIS) going to split?
There is no upcoming split for Curis.
What sector and industry does Curis (CRIS) operate in?
Curis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Curis Stock (NASDAQ:CRIS), Quotes and News Summary
Curis Stock (NASDAQ: CRIS) stock price, news, charts, stock research, profile.
| Open6.000 | Close- |
| Vol / Avg.85.796K / 17.185K | Mkt Cap866.035M |
| Day Range6.000 - 7.431 | 52 Wk Range7.600 - 20.000 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.120 | -0.120 | 0.0000 | ||||
| REV | 2.570M | 2.197M | -373.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-25 | HC Wainwright & Co. | Edward White | Reiterates | BuyBuy | Maintains | - | 6.00 |
| 2023-09-07 | Cantor Fitzgerald | Alethia Young | Reiterates | OverweightOverweight | Maintains | - | 3.00 |
| 2023-08-04 | HC Wainwright & Co. | Edward White | Reiterates | BuyBuy | Maintains | - | 6.00 |
| 2023-07-11 | Cantor Fitzgerald | Alethia Young | Reiterates | OverweightOverweight | Maintains | - | 3.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| CRIS | Curis | 1836.24% | 866M |
| AGLE | Aeglea BioTherapeutics | 0.17% | 46.5M |
| GANX | Gain Therapeutics | 18.18% | 47.9M |
| CNTB | Connect Biopharma Hldgs | -0.17% | 41M |
| VTGN | Vistagen Therapeutics | 0.58% | 48.8M |
How do I buy Curis (CRIS) stock?
You can purchase shares of Curis (NASDAQ: CRIS) through any online brokerage.
Who are Curis's (CRIS) competitors?
Other companies in Curis’s space includes: Aeglea BioTherapeutics (NASDAQ:AGLE), Gain Therapeutics (NASDAQ:GANX), Connect Biopharma Hldgs (NASDAQ:CNTB), Vistagen Therapeutics (NASDAQ:VTGN) and Longeveron (NASDAQ:LGVN).
What is the target price for Curis (CRIS) stock?
The latest price target for Curis (NASDAQ: CRIS) was reported by HC Wainwright & Co. on Monday, September 25, 2023. The analyst firm set a price target for 6.00 expecting CRIS to fall to within 12 months (a possible -18.45% downside). 7 analyst firms have reported ratings in the last year.
Current Stock Price for Curis (CRIS)?
The stock price for Curis (NASDAQ: CRIS) is $7.3577 last updated Today at September 29, 2023 at 2:32 PM UTC.
Does Curis (CRIS) pay a dividend?
There is no dividend information for Curis.
When is Curis (NASDAQ:CRIS) reporting earnings?
Curis’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
Is Curis (CRIS) going to split?
There is no upcoming split for Curis.
What sector and industry does Curis (CRIS) operate in?
Curis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Curis Stock (NASDAQ:CRIS), Quotes and News Summary
Curis Stock (NASDAQ: CRIS) stock price, news, charts, stock research, profile.
| Open6.000 | Close- |
| Vol / Avg.85.796K / 17.185K | Mkt Cap866.035M |
| Day Range6.000 - 7.431 | 52 Wk Range7.600 - 20.000 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.120 | -0.120 | 0.0000 | ||||
| REV | 2.570M | 2.197M | -373.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-25 | HC Wainwright & Co. | Edward White | Reiterates | BuyBuy | Maintains | - | 6.00 |
| 2023-09-07 | Cantor Fitzgerald | Alethia Young | Reiterates | OverweightOverweight | Maintains | - | 3.00 |
| 2023-08-04 | HC Wainwright & Co. | Edward White | Reiterates | BuyBuy | Maintains | - | 6.00 |
| 2023-07-11 | Cantor Fitzgerald | Alethia Young | Reiterates | OverweightOverweight | Maintains | - | 3.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| CRIS | Curis | 1836.24% | 866M |
| AGLE | Aeglea BioTherapeutics | 0.17% | 46.5M |
| GANX | Gain Therapeutics | 18.18% | 47.9M |
| CNTB | Connect Biopharma Hldgs | -0.17% | 41M |
| VTGN | Vistagen Therapeutics | 0.58% | 48.8M |
How do I buy Curis (CRIS) stock?
You can purchase shares of Curis (NASDAQ: CRIS) through any online brokerage.
Who are Curis's (CRIS) competitors?
Other companies in Curis’s space includes: Aeglea BioTherapeutics (NASDAQ:AGLE), Gain Therapeutics (NASDAQ:GANX), Connect Biopharma Hldgs (NASDAQ:CNTB), Vistagen Therapeutics (NASDAQ:VTGN) and Longeveron (NASDAQ:LGVN).
What is the target price for Curis (CRIS) stock?
The latest price target for Curis (NASDAQ: CRIS) was reported by HC Wainwright & Co. on Monday, September 25, 2023. The analyst firm set a price target for 6.00 expecting CRIS to fall to within 12 months (a possible -18.45% downside). 7 analyst firms have reported ratings in the last year.
Current Stock Price for Curis (CRIS)?
The stock price for Curis (NASDAQ: CRIS) is $7.3577 last updated Today at September 29, 2023 at 2:32 PM UTC.
Does Curis (CRIS) pay a dividend?
There is no dividend information for Curis.
When is Curis (NASDAQ:CRIS) reporting earnings?
Curis’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
Is Curis (CRIS) going to split?
There is no upcoming split for Curis.
What sector and industry does Curis (CRIS) operate in?
Curis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Curis Stock (NASDAQ:CRIS), Quotes and News Summary
Curis Stock (NASDAQ: CRIS) stock price, news, charts, stock research, profile.
| Open6.000 | Close- |
| Vol / Avg.85.796K / 17.185K | Mkt Cap866.035M |
| Day Range6.000 - 7.431 | 52 Wk Range7.600 - 20.000 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.120 | -0.120 | 0.0000 | ||||
| REV | 2.570M | 2.197M | -373.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-25 | HC Wainwright & Co. | Edward White | Reiterates | BuyBuy | Maintains | - | 6.00 |
| 2023-09-07 | Cantor Fitzgerald | Alethia Young | Reiterates | OverweightOverweight | Maintains | - | 3.00 |
| 2023-08-04 | HC Wainwright & Co. | Edward White | Reiterates | BuyBuy | Maintains | - | 6.00 |
| 2023-07-11 | Cantor Fitzgerald | Alethia Young | Reiterates | OverweightOverweight | Maintains | - | 3.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| CRIS | Curis | 1836.24% | 866M |
| AGLE | Aeglea BioTherapeutics | 0.17% | 46.5M |
| GANX | Gain Therapeutics | 18.18% | 47.9M |
| CNTB | Connect Biopharma Hldgs | -0.17% | 41M |
| VTGN | Vistagen Therapeutics | 0.58% | 48.8M |
How do I buy Curis (CRIS) stock?
You can purchase shares of Curis (NASDAQ: CRIS) through any online brokerage.
Who are Curis's (CRIS) competitors?
Other companies in Curis’s space includes: Aeglea BioTherapeutics (NASDAQ:AGLE), Gain Therapeutics (NASDAQ:GANX), Connect Biopharma Hldgs (NASDAQ:CNTB), Vistagen Therapeutics (NASDAQ:VTGN) and Longeveron (NASDAQ:LGVN).
What is the target price for Curis (CRIS) stock?
The latest price target for Curis (NASDAQ: CRIS) was reported by HC Wainwright & Co. on Monday, September 25, 2023. The analyst firm set a price target for 6.00 expecting CRIS to fall to within 12 months (a possible -18.45% downside). 7 analyst firms have reported ratings in the last year.
Current Stock Price for Curis (CRIS)?
The stock price for Curis (NASDAQ: CRIS) is $7.3577 last updated Today at September 29, 2023 at 2:32 PM UTC.
Does Curis (CRIS) pay a dividend?
There is no dividend information for Curis.
When is Curis (NASDAQ:CRIS) reporting earnings?
Curis’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
Is Curis (CRIS) going to split?
There is no upcoming split for Curis.
What sector and industry does Curis (CRIS) operate in?
Curis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.